Pneumonitis after Stereotactic Thoracic Radioimmunotherapy with Checkpoint Inhibitors: Exploration of the Dose–Volume–Effect Correlation

Pneumonitis after Stereotactic Thoracic Radioimmunotherapy with Checkpoint Inhibitors: Exploration of the Dose–Volume–Effect Correlation

Thoracic stereotactic body radiation therapy (SBRT) is extensively used in combination with immune checkpoint blockade (ICB). While current evidence suggests that the occurrence of pneumonitis as a side effect of both treatments is not enhanced for the combination, the dose–volume correlation remain...

Full description

Bibliographic Details
Main Authors: Kim Melanie Kraus, Caroline Bauer, Benedikt Feuerecker, Julius Clemens Fischer, Kai Joachim Borm, Denise Bernhardt, Stephanie Elisabeth Combs
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Series:Cancers
Subjects:
radioimmunotherapy (RIT)
checkpoint inhibitors
stereotactic body radiation therapy (SBRT)
lung cancer
Online Access:https://www.mdpi.com/2072-6694/14/12/2948

Internet

https://www.mdpi.com/2072-6694/14/12/2948

Similar Items